|
HS Code |
545708 |
| Cas Number | 57-97-6 |
| Molecular Formula | C20H16 |
| Molecular Weight | 256.34 g/mol |
| Appearance | Yellow crystalline powder |
| Melting Point | 122-124°C |
| Solubility In Water | Insoluble |
| Density | 1.19 g/cm³ |
| Synonyms | DMBA, 7,12-DMBA |
| Hazard Statements | Carcinogenic; Harmful by inhalation, ingestion or skin contact |
| Iupac Name | 7,12-dimethylbenzo[a]anthracene |
| Flash Point | 243°C (open cup) |
| Storage Temperature | Store at 2-8°C, protect from light |
| Pubchem Cid | 9116 |
As an accredited 7,12-Dimethylbenz[A]Anthracene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 1 gram of 7,12-Dimethylbenz[A]Anthracene, sealed with a screw cap, labeled with hazard warnings. |
| Shipping | Shipping of **7,12-Dimethylbenz[a]anthracene** must comply with hazardous material regulations. It should be packed in tightly sealed, chemical-resistant containers, labeled with hazard warnings, and handled by trained personnel. Transport requires secondary containment to prevent leaks or spills, and documentation must include safety and emergency response information as required by international shipping standards. |
| Storage | 7,12-Dimethylbenz[a]anthracene should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. Keep container tightly closed and clearly labeled. Store separately from incompatible substances, such as strong oxidizers. Use appropriate chemical storage cabinets, ideally flammable or carcinogen-designated, and ensure access is restricted to authorized personnel using proper personal protective equipment. |
Applications of 7,12-Dimethylbenz[A]Anthracene in Industrial ManufacturingAs a manufacturer specializing in 7,12-Dimethylbenz[A]Anthracene, our raw material supports several advanced R&D and quality control workflows across select industrial domains. The following sections detail typical downstream applications, as verified by regulation and industry practice, encompassing process parameters, compliance needs, and end-market product outcomes. 1. Carcinogenicity Testing Reference Standard for Preclinical ResearchLeading laboratories and pharmaceutical quality control units rely on our material as a key reference standard in carcinogenicity assays, establishing toxicological profiles for regulatory submissions. During study design, labs dissolve the compound in bio-compatible solvents prior to administration in animal models. All handling occurs within negative-pressure environments to minimize occupational risk and ensure compliance protocols are met. Quality inspection teams run concurrent LC-MS or HPLC batch testing to validate material identity against known spectral signatures and purity runs above 98% to support assay reliability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Polycyclic Aromatic Hydrocarbon (PAH) Analytical Standard in Environmental MonitoringOur material serves as a critical calibrant and control in environmental and food safety laboratories conducting quantitative PAH analysis by gas chromatography/mass spectrometry (GC/MS) or high-performance liquid chromatography (HPLC). Sample processing teams spike matrix samples with defined concentrations for analyte recovery studies. Stringent documentation accompanies all supplied batches, supporting traceability and method validation with cross-lab reproducibility standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chemical Mutagen Screening Systems for Research UseOur material provides mutagen controls in genotoxicology screens, supporting the validation of new chemical entities in biotech and pharmaceutical laboratories. Research chemists dissolve the compound for use in in vitro and in vivo mutagenicity assays, including the Ames bacterial reverse mutation test, mouse micronucleus assay, and DNA adduct formation studies. Timely batch-release data support laboratory traceability, and batch-specific risk assessments provide all end users with regulatory documentation for test system compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Epidemiological and Biomarker Research for Occupational Exposure StudiesOccupational health agencies and academic research units employ our product in biomonitoring studies, correlating exposure to PAHs in industrial settings with the formation of DNA adducts or serum metabolites in human blood and tissue samples. All distribution and use adhere to local health and safety legislation concerning controlled carcinogenic substances, with extensive chain-of-custody and risk management processes in place to facilitate compliant research deployments. Each lot manufactures with traceable full-synthesis documentation and is accompanied by independent spectral and chromatographic verification for surveillance register compatibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 7,12-Dimethylbenz[A]Anthracene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of 7,12-Dimethylbenz[a]anthracene we produce comes from a carefully controlled multi-stage process, refined over years of chemical manufacturing experience. This polycyclic aromatic hydrocarbon holds a unique place in laboratories, supporting a wide range of applications that would falter without its defined molecular structure and distinct properties. Our journey with this compound began with modest runs. Today, increasing research interest and regulatory scrutiny have shaped how we handle, package, and deliver our 7,12-Dimethylbenz[a]anthracene, from raw material selection to technical documentation.
What sets 7,12-Dimethylbenz[a]anthracene apart in the chemical family is its complex aromatic structure — a benz[a]anthracene backbone, substituted with methyl groups at the 7 and 12 positions. This structure influences both its chemical behavior and its biological relevance. In practical manufacturing terms, this means stringent attention to purity as well as crystallinity. Contaminants compromise assay results and biological studies, so we put batch material through multiple rounds of recrystallization and chromatography before it moves on to packaging. Typical purity levels reach above 98%, and we routinely verify this through advanced HPLC and NMR analysis. Our plant operates under strict temperature and atmosphere controls, and we find these measures bring consistent results, both in product quality and shelf stability.
Unlike some lower-purity or technical-grade aromatics, our 7,12-Dimethylbenz[a]anthracene meets research-grade standards—each batch provides researchers precision rather than guesswork. The physical appearance is fine, pale yellow powder, with distinct melting points and solubility characteristics. Not all suppliers take such care to eliminate by-products—slight isomers, residual solvents, or oxidation products—that become problematic downstream. Years of feedback from academic and industrial partners taught us that small impurities produce major difference in sensitive assays, so we designed our process to minimize these issues.
Research settings rely on 7,12-Dimethylbenz[a]anthracene as a model compound. Scientists studying mutagenicity and carcinogenicity often select this material due to its robust and well-characterized biological effects. Our production sees orders from toxicology labs, oncology researchers, and molecular biologists investigating DNA-adduct formation, tumor initiation, and metabolic activation of aromatic hydrocarbons. Having sat in on discussions with research partners, we know the rigors of experimental design and why reproducibility matters. Projects using this compound often have wide-reaching consequences; small errors ripple through published data. As a manufacturer, we treat this as an ethical responsibility.
We also see orders from environmental monitoring groups. 7,12-Dimethylbenz[a]anthracene acts as an indicator or positive control for detecting PAH contamination in soil, water, and air. The compound’s behavior in analytical systems provides a benchmark for other PAHs, offering clarity when regulatory agencies place infrastructure and public health under the microscope. Any deviation in composition becomes magnified in high-sensitivity assays—hence our insistence on rigorous batch testing.
Polycyclic aromatic hydrocarbons form a crowded family, yet not every member sparks the same level of interest, nor poses the same manufacturing challenges. We’ve worked with several related compounds, such as benzo[a]pyrene and chrysene, and the distinctions are more than academic. 7,12-Dimethylbenz[a]anthracene stands apart due to its potent biological profile combined with chemical stability under laboratory conditions. Unlike unsubstituted benz[a]anthracene, this dimethyl derivative invokes well-defined tumorigenic responses in model systems—making it the compound of choice for dose-response studies and mechanism investigations.
Some laboratories inquire about cost savings by using generic benzanthracenes or technical-grade mixtures, but our experience tells us the risk rarely justifies the savings. Inferior grades deliver inconsistent results, and even trace contamination with regioisomers interrupts metabolic pathways in test organisms or cells. In our catalog, the clean separation and isolation of 7,12-Dimethylbenz[a]anthracene gives it a unique identity. Researchers using our high-purity product report fewer confounding variables, more robust assays, and easier reproducibility across collaborating labs.
Looking further, we respond to increasing demands for environmentally conscious production. Many downplay differences in synthetic routes, but our adjustment to solvent recycling and minimal-waste workups—even at higher production cost—delivers product without the environmental baggage of less selective syntheses. Other PAHs, often produced at multi-ton scale for industrial uses, receive little purification. By contrast, our product balances tradition and innovation, blending organic synthesis experience with real-world practicality.
Chemical manufacturing has always walked the line between efficiency and responsibility. Every production run of 7,12-Dimethylbenz[a]anthracene begins with raw material sourcing. We vet suppliers for both reliability and transparency; unvetted intermediates bring future headaches for both us and our customers. Each synthesis involves careful temperature control and atmospheric exclusion—oxygen and moisture degrade both yield and purity. Post-reaction workup matters. We prefer recrystallization over fast precipitation, since slower growth provides clearer crystals and reduces inclusion of unwanted species.
We keep production in-house, closely monitoring each recrystallization and chromatographic purification. Colleagues on the line understand the stakes—no batch passes without first meeting HPLC, GC-MS, and NMR benchmarks. Occasionally, impurities creep in through aging solvents or unclean glassware, so we trace every analytical anomaly back to its source. Our lab notebooks fill with test results and corrective actions, forming an auditable chain researchers can rely on. These behind-the-scenes choices play out in the precise melting point and clear spectra seen by our clients.
Safety remains a constant concern. 7,12-Dimethylbenz[a]anthracene, like many PAHs, brings hazards beyond the obvious. Our facility trains every worker on controlled handling, personal protective equipment, and ventilation best practices. Internal protocols match the substance’s risks, including working only in fume hoods, avoiding open vessels, and following strict hygiene before breaks and at shift’s end. We see the hazards firsthand; as a manufacturer, communicating risk transparently goes hand-in-hand with supplying high-purity products.
In research and regulation, quality control doesn’t stop at the lab door. Our clients, especially those publishing or submitting results to agencies, demand consistent composition, batch-to-batch traceability, and clear documentation. From the beginning, our manufacturing philosophy focused on writing clear, comprehensive certificates of analysis. Each lot receives not just purity data but detailed spectral fingerprints, melting behavior, and physical descriptions. We store reference samples from every run, giving long-term reproducibility even when methods change or research projects extend over years.
As environmental and occupational health regulations evolve, we see demand rising for cleaner, more traceable PAHs. Regulatory limits keep tightening, so we extend our analytical profiles to detect sub-ppm contaminant levels and breakdown products. Academic collaborators rely on our ability to answer probing questions—What’s the bis-methyl isomer content? Which solvents or metal ions lurk in trace form? Having developed and tested our own purification columns and workups, we speak from practice, not just theory. This experience-driven approach sets the bar high for product integrity.
We regularly field inquiries from labs developing new models for metabolic activation, DNA repair, or carcinogen screening, and many fact-check our data against their own observations. Open data exchange proves key; we invite customers to challenge our results. Problems identified through use—unexpected byproducts, minor spectral shifts—become points for continuous improvement. This practical loop between manufacturer and end-user stands behind every bottle bearing our label.
The future of PAHs in science and industry presents both hurdles and opportunities. While 7,12-Dimethylbenz[a]anthracene remains irreplaceable in classic experiments, regulatory and public concerns over hazardous research chemicals grow each year. From our vantage point, the rush to legislate sometimes outpaces tool development or scientific understanding. We engage with regulatory agencies directly, advocating for standards that permit critical research without sacrificing worker or public safety.
Hazard labeling, safe transport, and waste management demand more effort than ever. We overhaul packaging not just for compliance but for real-world lab safety—screwcap bottles with liners, inert gas backfilling, and tamper-evident seals cut down on contamination and accidental exposure. Returnable container programs and solvent recycling reduce downstream waste—these changes reduce cost over time rather than adding it. Our engineering staff routinely update safety protocols and work with customers to implement best practices for use and disposal.
Moving beyond compliance, outreach and transparency have grown into core parts of our manufacturing process. Chemists who order our 7,12-Dimethylbenz[a]anthracene often need technical support, both for handling and experiment design. Our team collaborates over the phone, by email, and even in-person with research groups designing new bioassays or environmental screening protocols.
As more jurisdictions tighten rules on PAHs, disposal and spill protocols grow in importance. We supply not just technical support but practical advice: how to set up spill kits; how to minimize experiment scale; how to design workflows for minimal personnel exposure. Our laboratory hazard assessments and safety data sheets undergo yearly review to reflect the latest science, not just compliance standards. Over the years we’ve noticed a confident user works more safely; clear, unembellished training always beats boilerplate warnings.
Our manufacturing team stays on the lookout for better ways to synthesize and refine 7,12-Dimethylbenz[a]anthracene. Existing methods work, but incremental improvements ripple into better yield, higher purity, and less environmental impact. For example, shifting to greener solvents and utilizing flow chemistry for certain steps has reduced off-gassing and solvent consumption. Controlling light exposure during synthesis and storage further stabilizes the product, especially over the long time frames required for reference materials.
We invest in analytical instrumentation, upgrading to the latest chromatography columns and automated sample injectors, which frees our chemists to spend time on problem-solving rather than routine monitoring. Comparing results batch by batch, we spot trends early. Process tweaks—lowering reaction timeouts, switching to high-purity reagents, or optimizing filtration rates—stem from direct observations while working the line. In another example, we added UV-light protection film to our packaging line after detecting small degradants linked to fluorescent lighting.
Customer feedback feeds into development as well. Requests for larger pack sizes, custom dilutions, or pre-weighed aliquots moved us to reconfigure our packaging and inventory systems. Intake procedures now include customized batch splitting, so even specialized research teams receive materials matched in both size and lot, minimizing the risk of inadvertent experimental variance. These adjustments, based on real-world use, create value both for the researcher and for us as the supplier.
Working directly with research end-users gives us a depth of insight rarely matched by traders or third-party resellers. Clients in academic labs, pharmaceutical research, and environmental monitoring often reach out for more than just supply—they want guidance, troubleshooting, and honest conversation on process improvement. We've found the direct channel allows both rapid response and deeper support. Sometimes this takes the form of overnight resupply after damaged shipments; in other cases, we offer technical troubleshooting for inconsistent assay data or suspected environmental degradation.
Unlike intermediaries who source material based on availability and margins, we can commit to consistent synthetic routes and finished product. There have been years where global shortages of precursor materials tested both supply and patience, yet our in-house process flexibility allowed us to maintain output and keep quality high. For the most part, working as a direct manufacturer lets us implement changes, reward attention to detail among staff, and reinvest in safer, more reliable production infrastructure.
By keeping production and support close, we trace every bottle’s journey from precursor delivery to client shipment—no gaps, no guessing. As demand grows and applications broaden, this direct partnership with the scientific community lets us stay ahead of new challenges, whether analytical, regulatory, or technical.
Supplying 7,12-Dimethylbenz[a]anthracene isn’t just a transactional business. The work touches foundational issues in toxicology, cancer biology, and public health. As research evolves, so do our responsibilities as both supplier and stakeholder. We recognize every package shipped represents an experiment, a publication, or a contribution to the broader understanding of chemical hazard and biological effect.
Our team keeps learning alongside customers and partners. Improved analytical methods, evolving safety protocols, and growing environmental awareness drive each improvement to both chemistry and customer service. While regulations shape much of what’s possible, practical know-how and scientific exchange shape what’s effective in the real world. We remain committed to pairing product quality with honest, experience-driven support—two things that, year after year, prove as important as the compound inside the bottle.